BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 33994851)

  • 1. CHD4 as an important mediator in regulating the malignant behaviors of colorectal cancer.
    Chang CL; Huang CR; Chang SJ; Wu CC; Chen HH; Luo CW; Yip HK
    Int J Biol Sci; 2021; 17(7):1660-1670. PubMed ID: 33994851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CHD4 Has Oncogenic Functions in Initiating and Maintaining Epigenetic Suppression of Multiple Tumor Suppressor Genes.
    Xia L; Huang W; Bellani M; Seidman MM; Wu K; Fan D; Nie Y; Cai Y; Zhang YW; Yu LR; Li H; Zahnow CA; Xie W; Chiu Yen RW; Rassool FV; Baylin SB
    Cancer Cell; 2017 May; 31(5):653-668.e7. PubMed ID: 28486105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The NuRD complex-mediated p21 suppression facilitates chemoresistance in BRCA-proficient breast cancer.
    Hou MF; Luo CW; Chang TM; Hung WC; Chen TY; Tsai YL; Chai CY; Pan MR
    Exp Cell Res; 2017 Oct; 359(2):458-465. PubMed ID: 28842166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The NuRD complex cooperates with DNMTs to maintain silencing of key colorectal tumor suppressor genes.
    Cai Y; Geutjes EJ; de Lint K; Roepman P; Bruurs L; Yu LR; Wang W; van Blijswijk J; Mohammad H; de Rink I; Bernards R; Baylin SB
    Oncogene; 2014 Apr; 33(17):2157-68. PubMed ID: 23708667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CHD4 regulates platinum sensitivity through MDR1 expression in ovarian cancer: A potential role of CHD4 inhibition as a combination therapy with platinum agents.
    Oyama Y; Shigeta S; Tokunaga H; Tsuji K; Ishibashi M; Shibuya Y; Shimada M; Yasuda J; Yaegashi N
    PLoS One; 2021; 16(6):e0251079. PubMed ID: 34161330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defeating EpCAM(+) liver cancer stem cells by targeting chromatin remodeling enzyme CHD4 in human hepatocellular carcinoma.
    Nio K; Yamashita T; Okada H; Kondo M; Hayashi T; Hara Y; Nomura Y; Zeng SS; Yoshida M; Hayashi T; Sunagozaka H; Oishi N; Honda M; Kaneko S
    J Hepatol; 2015 Nov; 63(5):1164-72. PubMed ID: 26095183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CHD4 Is a Peripheral Component of the Nucleosome Remodeling and Deacetylase Complex.
    Low JK; Webb SR; Silva AP; Saathoff H; Ryan DP; Torrado M; Brofelth M; Parker BL; Shepherd NE; Mackay JP
    J Biol Chem; 2016 Jul; 291(30):15853-66. PubMed ID: 27235397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The epigenetic factor CHD4 contributes to metastasis by regulating the EZH2/β-catenin axis and acts as a therapeutic target in ovarian cancer.
    Wang J; Zhong F; Li J; Yue H; Li W; Lu X
    J Transl Med; 2023 Jan; 21(1):38. PubMed ID: 36681835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CHD4-mediated loss of E-cadherin determines metastatic ability in triple-negative breast cancer cells.
    Luo CW; Wu CC; Chang SJ; Chang TM; Chen TY; Chai CY; Chang CL; Hou MF; Pan MR
    Exp Cell Res; 2018 Feb; 363(1):65-72. PubMed ID: 29305962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Helicase CHD4 is an epigenetic coregulator of PAX3-FOXO1 in alveolar rhabdomyosarcoma.
    Böhm M; Wachtel M; Marques JG; Streiff N; Laubscher D; Nanni P; Mamchaoui K; Santoro R; Schäfer BW
    J Clin Invest; 2016 Nov; 126(11):4237-4249. PubMed ID: 27760049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RNAi screens identify CHD4 as an essential gene in breast cancer growth.
    D'Alesio C; Punzi S; Cicalese A; Fornasari L; Furia L; Riva L; Carugo A; Curigliano G; Criscitiello C; Pruneri G; Pelicci PG; Faretta M; Bossi D; Lanfrancone L
    Oncotarget; 2016 Dec; 7(49):80901-80915. PubMed ID: 27779108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CHD4 Predicts Aggressiveness in PTC Patients and Promotes Cancer Stemness and EMT in PTC Cells.
    Pratheeshkumar P; Siraj AK; Divya SP; Parvathareddy SK; Alobaisi K; Al-Sobhi SS; Al-Dayel F; Al-Kuraya KS
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33419089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of CHD4-β1 integrin axis as a prognostic marker in triple-negative breast cancer using next-generation sequencing and bioinformatics.
    Ou-Yang F; Pan MR; Chang SJ; Wu CC; Fang SY; Li CL; Hou MF; Luo CW
    Life Sci; 2019 Dec; 238():116963. PubMed ID: 31639396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CHD4 mediates proliferation and migration of non-small cell lung cancer via the RhoA/ROCK pathway by regulating PHF5A.
    Xu N; Liu F; Wu S; Ye M; Ge H; Zhang M; Song Y; Tong L; Zhou J; Bai C
    BMC Cancer; 2020 Mar; 20(1):262. PubMed ID: 32228507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NuRD subunit CHD4 regulates super-enhancer accessibility in rhabdomyosarcoma and represents a general tumor dependency.
    Marques JG; Gryder BE; Pavlovic B; Chung Y; Ngo QA; Frommelt F; Gstaiger M; Song Y; Benischke K; Laubscher D; Wachtel M; Khan J; Schäfer BW
    Elife; 2020 Aug; 9():. PubMed ID: 32744500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acetyltransferase p300 collaborates with chromodomain helicase DNA-binding protein 4 (CHD4) to facilitate DNA double-strand break repair.
    Qi W; Chen H; Xiao T; Wang R; Li T; Han L; Zeng X
    Mutagenesis; 2016 Mar; 31(2):193-203. PubMed ID: 26546801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Over-Expression of CHD4 Is an Independent Biomarker of Poor Prognosis in Patients with Rectal Cancers Receiving Concurrent Chemoradiotherapy.
    Wang HC; Chou CL; Yang CC; Huang WL; Hsu YC; Luo CW; Chen TJ; Li CF; Pan MR
    Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31438571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chromodomain helicase DNA-binding protein 4 (CHD4) regulates homologous recombination DNA repair, and its deficiency sensitizes cells to poly(ADP-ribose) polymerase (PARP) inhibitor treatment.
    Pan MR; Hsieh HJ; Dai H; Hung WC; Li K; Peng G; Lin SY
    J Biol Chem; 2012 Feb; 287(9):6764-72. PubMed ID: 22219182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-761 inhibits colorectal cancer cell proliferation and invasion through targeting HDAC1.
    Xiong W; Yang S; Zhang W; Chen Y; Wang F
    Pharmazie; 2019 Feb; 74(2):111-114. PubMed ID: 30782261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CHD4 regulates the DNA damage response and RAD51 expression in glioblastoma.
    McKenzie LD; LeClair JW; Miller KN; Strong AD; Chan HL; Oates EL; Ligon KL; Brennan CW; Chheda MG
    Sci Rep; 2019 Mar; 9(1):4444. PubMed ID: 30872624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.